Hence, the immunogenic action of IFNγ may be inevitably accompanied by an elevated immune evasion mechanism (PD-L1, IDO1, and Arg1) in the tumor microenvironment, and a specific therapeutic combination may overcome this unwanted effect. Here, IDO1 is linked to neoplasm.